Lupin Looks To Be First Out Of The Blocks On US Ingrezza, With Zydus Second

US Ingrezza Legal Battles Wrapped Up, With Earlier Teva, Sandoz Deals

 
• By Dean Rudge
  
Enter The Fray
• Source: Alamy
Generics Bulletin Podcast

Stay ahead of every shift in generics and biosimilars.

Generics Bulletin brings you the latest updates that matter for the off-patent industry.

SpotifyApple PodcastsWebsite

More from Generics

More from Products